Organization: Health Canada
Year: 2021
Month: December
Request Number: A-2021-001323
Request Summary: Total number of Clinical Trial Applications (CTA) involving the drug name "psilocybin" for the period between Q1 2017 and Q4 2021 Nationwide and or by province and territory. Total number of exemptions issued by Health Canada under Subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) involving: patient access to psilocybin, practitioner access to psilocybin and pharmacist access to psilocybin for the period between Q1 2017 and Q4 2021 Nationwide and or by province and territory.
Disposition: All disclosed
Number of pages: 2